A new publication concerning CRAMP, the murine antimicrobial peptide related to human LL-37, appeared on August 28, 2026. The paper, titled "The Murine Antimicrobial Peptide CRAMP Alleviates Neuroinflammation By Downregulating the cGAS-STING Signalling Pathway," was published in the journal Molecular Neurobiology.
The publication is indexed on PubMed under record ID 42663760. This brief reports only that the study exists and was published, based on the title and journal listing provided. No specific findings, data, or conclusions from within the paper are described here beyond what the title itself states.
LL-37 remains classified as an unapproved compound used in research settings. CRAMP is described in scientific literature as the murine counterpart to human LL-37, and studies involving CRAMP are sometimes referenced in LL-37 research contexts due to their structural and functional relationship.
Readers interested in the broader research landscape around this peptide family can consult the compound overview for additional context.